All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Phentermine or a GLP-1 drug: how weight loss results, side effects and costs differ

GLP-1 drugs showed about 15% to 20% weight loss over 12 to 18 months; phentermine about 5% to 10%. See how each works, side effects, and cost.

By FormBlends Editorial Research|Reviewed by FormBlends Medical Team||
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

If you're researching weight management medications, you have probably come across both GLP-1 medications and phentermine. This GLP-1 vs phentermine weight loss resource covers the important information you need to make informed decisions.

If you're researching weight management medications, you have probably come across both GLP-1 medications and phentermine. This GLP-1 vs phentermine weight loss resource covers the important information you need to make informed decisions. These are fundamentally different drugs with different mechanisms, different timelines, and different risk profiles. This GLP-1 vs phentermine comparison gives you the facts so you can have an informed conversation with your provider about which approach may fit your situation.

Key Takeaways: - Learn how each medication works - Efficacy: Weight Loss Results Compared - Side Effects: Different Risk Profiles - Duration of Use: Short-Term vs Long-Term - Cost Comparison: What Each Option Costs.

How GLP-1 drugs and phentermine act on appetite and metabolism

Feature GLP-1 Medications Phentermine
Mechanism GLP-1 receptor agonist Sympathomimetic amine (stimulant)
Weight loss (typical) 15-22% 5-10%
Administration Weekly injection Oral (daily)
Duration of use Long-term / indefinite Short-term (12 weeks typical)
DEA schedule Not scheduled Schedule IV controlled
Common side effects Nausea, GI symptoms Insomnia, improved heart rate
Monthly cost $150-$1,500 $10-$50 (generic)

GLP-1 medications and phentermine approach weight management from completely different angles.

GLP-1 receptor agonists (semaglutide, tirzepatide) mimic a natural gut hormone called glucagon-like peptide-1. This hormone signals your brain that you're full, slows stomach emptying so food stays in your system longer, and helps regulate blood sugar levels. The result is reduced appetite and earlier satiety) you feel satisfied with less food, naturally.

GLP-1 medications are injected once weekly (subcutaneously) and work around the clock. The appetite reduction feels gradual and natural rather than forced. Many patients describe it as the constant food noise in their head going quiet.

Phentermine is a sympathomimetic amine (a stimulant that acts on your central nervous system. It triggers the release of norepinephrine, a neurotransmitter that suppresses appetite through the fight-or-flight pathway. it puts your body in a mild state of arousal that overrides hunger signals.

Phentermine is taken orally as a daily pill. It works quickly) most people notice appetite suppression within the first few days. But the effect tends to diminish over time as the body develops tolerance.

"We now have cardiovascular outcomes data showing semaglutide reduces MACE events by 20% in people with obesity, independent of diabetes status. The SELECT trial[1] changed how we think about these medications.", Dr. A. Michael Lincoff, MD, Cleveland Clinic, lead author of SELECT

For a deeper look at how GLP-1 medications work, read our.

Weight loss results for GLP-1 drugs versus phentermine over 12 months

The clinical data shows a significant difference in average weight loss between these two approaches.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92First month $99 (semaglutide) or $149 (tirzepatide), then $190 or $239 per month, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Is phentermine a GLP-1? How the two weight loss drugs compare: stethoscope draped over a medical chart on a white surface

GLP-1 medications: Clinical trials show approximately 15% to 20% total body weight loss over 12 to 18 months, depending on the specific medication and dose. Semaglutide studies showed approximately 15% average loss. Tirzepatide studies showed approximately 20% at the highest dose. These results were achieved alongside dietary counseling and physical activity.


Free Download: GLP-1 Decision Matrix Worksheet Compare your medication options side by side. Our printable worksheet helps you organize efficacy, cost, side effects, and lifestyle factors before your provider visit. Get yours free (we'll email it to you instantly. [Download Now]


Phentermine: Clinical trials show approximately 5% to 10% total body weight loss over 3 to 6 months. A meta-analysis of phentermine studies found an average of about 7% body weight loss compared to placebo. Results vary widely between individuals.

Why the difference? Three main factors explain the gap. First, GLP-1 medications target the biological system that regulates appetite in a more targeted way. Second, GLP-1 medications are used for longer periods (months to years), allowing for sustained, gradual loss. Third, the weekly injection format of GLP-1s provides consistent medication levels, while daily oral phentermine levels fluctuate.

But direct head-to-head trials between GLP-1 medications and phentermine are limited. The comparisons above draw from separate trial populations, which introduces variables.

Side effect differences between GLP-1 injections and phentermine pills

These medications have very different side effect profiles because they work through different mechanisms.

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →

GLP-1 side effects (most common): - Nausea (usually in early weeks, improves with dose titration) - Vomiting - Diarrhea or constipation - Abdominal discomfort - Fatigue.

GLP-1 side effects are primarily gastrointestinal. They tend to be worst during dose increases and improve as the body adjusts. The slow titration schedule) starting at a low dose and increasing gradually (specifically minimizes these effects.

Phentermine side effects (most common): - Increased heart rate - improved blood pressure - Insomnia - Dry mouth - Restlessness and anxiety - Headaches - Dizziness

Phentermine side effects reflect its stimulant nature. The cardiovascular effects (improved heart rate and blood pressure) are the primary safety concern and the main reason phentermine is limited to short-term use.

Serious risk differences: Phentermine isn't recommended for people with heart disease, uncontrolled high blood pressure, hyperthyroidism, or a history of substance use disorder. It has abuse potential and is classified as a Schedule IV controlled substance.

GLP-1 medications carry warnings about thyroid C-cell tumors (from animal studies), pancreatitis, and gallbladder problems. They aren't controlled substances and have no known abuse potential.

For strategies to manage GLP-1 side effects specifically, see our.

Phentermine duration limits: is it only approved for 12 weeks?

This is one of the biggest practical differences between these options.

Phentermine: Short-term only. The FDA approves phentermine for up to 12 weeks of use. Some providers prescribe it for longer periods off-label, but tolerance typically develops within a few months. The body adapts to the stimulant effect, and appetite suppression weakens. Most patients regain weight after stopping.

GLP-1 medications: Long-term use. GLP-1 medications are approved for ongoing, long-term use. Clinical studies lasting 2+ years show sustained weight management as long as the medication continues. Stopping GLP-1 medications typically results in partial to full weight regain over the following year, similar to phentermine.

What this means for you: If you're looking for a short-term boost to jump-start a lifestyle change, phentermine may serve that purpose. If you're looking for sustained, long-term weight management support, GLP-1 medications offer a more durable approach) though the commitment is also longer-term.

Your provider will help you decide which timeline matches your goals. to discuss your options.

Monthly out-of-pocket cost of GLP-1 drugs and phentermine

Cost varies significantly depending on insurance coverage, pharmacy, and location.

Phentermine: Relatively inexpensive. Generic phentermine costs approximately $15 to $50 per month without insurance. It's widely available and most insurance plans cover it.

Brand-name GLP-1 medications: Carry high retail prices. Without insurance, monthly costs can be substantial. Insurance coverage varies by plan and diagnosis.

Compounded GLP-1 medications through FormBlends: Compounded formulations containing the prescribed active pharmaceutical ingredient are significantly more affordable than brand-name versions. FormBlends offers transparent pricing with no hidden fees. Check our for current rates.

Cost over time: Because phentermine is used short-term (3 to 6 months), total cost is lower even though the per-month difference may be modest. GLP-1 medications used long-term represent an ongoing monthly expense. But the clinical outcomes data shows more sustained results with GLP-1 therapy.

Semaglutide and tirzepatide pricing from telehealth providers

FormBlends is a U.S. telehealth platform that prescribes compounded semaglutide and tirzepatide. Patients complete an online intake, a licensed provider reviews eligibility, and medication ships from a 503A compounding pharmacy. Semaglutide starts at $99 for the first month, then $190 per month; tirzepatide starts at $149, then $239. Start your intake.

Can you take phentermine and a GLP-1 drug together?

Some providers do prescribe combination therapy, though this is off-label. The combination may increase side effects, particularly nausea and cardiovascular effects. Never combine medications without your provider's explicit guidance and monitoring.

Phentermine's long history: does age mean it is safer?

Phentermine has been available since 1959, so its safety profile is well understood. But "longer history" doesn't automatically mean safer. Phentermine's stimulant effects and cardiovascular risks are well documented. GLP-1 medications have extensive clinical trial data and post-market surveillance supporting their safety profile.

Will weight come back after stopping GLP-1 drugs or phentermine?

Studies show weight regain is common after stopping both phentermine and GLP-1 medications. The degree of regain varies. Building sustainable dietary and exercise habits while on medication may help minimize regain. Your provider can create a plan for transitioning off medication when appropriate.

Which weight loss drug starts working faster?

Phentermine produces noticeable appetite suppression within days. GLP-1 medications show effects within the first week but reach full efficacy after several weeks of dose titration. But faster onset doesn't equal better long-term results.

Can you switch to a GLP-1 drug after using phentermine?

Previous phentermine use doesn't disqualify you from GLP-1 therapy. In fact, many patients who found phentermine helpful but limited by its short-term nature transition to GLP-1 medications for sustained support.

Talk to a licensed provider about GLP-1 or phentermine

Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you, consultations are free and confidential.


  1. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
  5. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
  6. Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
  7. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
  6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
  7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[5] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
  8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[6] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
  9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[7] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
  10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
  11. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. Doi:10.1056/NEJMoa1411892
  12. Marso SP, Daniels GH, Tanaka K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-322. Doi:10.1056/NEJMoa1603827

This article is for educational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Is phentermine a GLP-1? How the two weight loss drugs compare
FormBlends guide cover for Is phentermine a GLP-1? How the two weight loss drugs compare.

Research Snapshot

Head-to-head comparison
Page type
Head-to-head comparison
Page metadata
Page updated
2026-11-21
Page metadata
FormBlends official source
Official source
Calibrate official source
Official source
Hims official source
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-11-21.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Comparison decision path

Use this comparison to narrow the provider review question

Related treatment context

Is phentermine a GLP-1? How the two weight loss drugs compare should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

Compare available products and select the relevant treatment page for its specific next step.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Provider Comparisons

Semaglutide vs Metformin vs Phentermine for Weight Loss: Premium vs Budget Options

Compare semaglutide, metformin, and phentermine for weight loss. Detailed analysis of costs, effectiveness, and side effects to help you choose the right...

Patient Experience

Phentermine Weight Loss Results: What to Expect in Week 1 vs One Month (and Why the Timeline Matters More Than the Number)

What to expect from phentermine in week 1 vs one month: real clinical data on weight loss, appetite suppression timing, and when results plateau.

Provider Comparisons

Semaglutide Vs Phentermine: Complete Comparison

Semaglutide and phentermine take very different approaches to weight loss. Compare their mechanisms, effectiveness, side effects, and long-term suitability.

Provider Comparisons

Tirzepatide Vs Phentermine: Complete Comparison

Tirzepatide and phentermine represent old and new approaches to weight loss medication. Compare their efficacy, safety, duration of use, and cost.

Provider Comparisons

GLP-1 vs Phentermine Traditional Medication

Glp-1 vs Phentermine Traditional Medication. A detailed, evidence-based comparison to help you choose the right weight loss approach.

Provider Comparisons

GLP-1 vs Phentermine: Two Different Drug Classes, Two Different Use Cases

Phentermine is a 1959-approved short-term obesity drug that works as a sympathomimetic appetite suppressant. Includes 2026 evidence, safety boundaries, and what to.

Provider Comparisons

Does Insurance Cover GLP-1 Weight Loss

You've heard about semaglutide and tirzepatide for weight management. This does insurance cover GLP-1 weight loss resource covers the essential information you need to make informed decisions. You're interested.

Provider Comparisons

Semaglutide vs Phentermine: New vs Old School Weight Loss

Compare semaglutide vs phentermine for weight loss. Clinical trials, side effects, costs, and effectiveness compared. Expert analysis from FormBlends...

Provider Comparisons

Phendimetrazine vs Phentermine: Which Prescription Stimulant Produces Better Weight Loss, and Which Side-Effect Profile Can You Actually Tolerate?

Head-to-head comparison of phendimetrazine and phentermine for weight loss: efficacy data, side effects, abuse potential, and which patients respond best.

FormBlends for iPhone

Track your routine in the FormBlends app

Doses, schedules, reminders, meals and progress in one free iPhone app.

Free Tools

Calculators to support your weight loss journey.